ACB241108P4500
- 0.01
- -0.01-50.00%
Aurora Cannabis Newsroom
Correction to Aurora Cannabis 2Q Net Headline on Nov. 6
Roth MKM Maintains Aurora Cannabis(ACB.US) With Hold Rating, Cuts Target Price to $5.77
Aurora Vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
Roth MKM Sticks to Their Hold Rating for Aurora Cannabis (ACB)
Daily options recap | Coinbase's call option soared 81 times! "Trump trade" bullish news released; Tesla surged 14%, the highest profit from call options was 7 times.
Nvidia rose 4% last night with large buyers purchasing 0.0856 million units of call options expiring this Friday, involving $43.5051 million; The single-day surge of Coinbase attracted short sellers, with large investors betting over $0.2 billion on a bearish outlook.
Aurora Cannabis (ACB) Q2 2025 Earnings Call Transcript
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Earnings Call: Aurora Cannabis Reports Robust Q2 2025 Financials
Pre-Markets Surge on Historic Trump Victory
Aurora Cannabis Inc. (ACB) Q2 2025 Earnings Call Transcript Summary
Aurora Cannabis Inc. (ACB) Q2 2025 Earnings Call Transcript
Aurora Cannabis Shares Are Trading Lower. The Company Reported Q2 Financial Results.
Aurora Cannabis Reports Strong Q2 Growth Driven By International Medical Marijuana Sales
ACB in Charts: Medical Cannabis Revenue Jumps, Consumer Falls Y/Y in Q2
Aurora Cannabis Financial Update Shows Asset Decline
Aurora Cannabis Q2 Profit Advances
Aurora Cannabis 2Q Profit Rises
Aurora Cannabis | 6-K: Report of foreign private issuer (related to financial reporting)
Aurora Cannabis 2Q Net C$0.4M >ACB
Aurora Cannabis Q2 Sales $81.100M Beat $70.450M Estimate